Erectile dysfunction (ED) and testosterone deficiency (TD) are more common among men with testicular cancer, a new study finds. In a study of US male veterans, investigators matched 1754 patients with ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

T-DXd outperformed physician’s choice of chemotherapy regardless of patients’ disease burden or time to progression on prior therapy.

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a study published online Jan. 8 in npj Digital Medicine. Noting there are no personalized ...

Precision medicine is transforming nursing roles in clinical oncology, and nurses play an increasingly crucial role in implementing personalized therapy and improving patient outcomes.

Mean distance in American Indian-majority census tracts reduced with adjustment for rurality but was still 3.16 times that seen in White majority tracts. HealthDay News — Differences in distance ...

The median duration of response was 6 months. Treatment with pembrolizumab and fulvestrant provided disease control in half of patients with estrogen receptor (ER)-positive, HER2-negative ...

Patients had a higher risk of death if they received radiotherapy in the afternoon or at night. Receiving radiotherapy in the morning may improve survival in patients with nasopharyngeal carcinoma ...

The mortality rates were 15.5% for the ibrutinib group and 16.3% for the bendamustine group. Significant cardiovascular risks are associated with ibrutinib treatment in patients with chronic ...

In analysis of calibration, the ACS-SRC appeared to show correct calibration in predicting outcomes of surgical site infection, readmission, and the need for nursing care postdischarge in this ...